| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |